BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6406576)

  • 1. Treatment of ischemic digital ulcers with nitroglycerin ointment.
    Wheeland RG; Gilchrist RW; Young CJ
    J Dermatol Surg Oncol; 1983 Jul; 9(7):548-51. PubMed ID: 6406576
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sildenafil in the treatment of digital ulcers in patients with systemic sclerosis].
    Cairoli E; Garra V; Martínez M
    Actas Dermosifiliogr; 2009 Nov; 100(9):830-2. PubMed ID: 19889312
    [No Abstract]   [Full Text] [Related]  

  • 3. Digital ulcers and outcomes assessment in scleroderma.
    Matucci-Cerinic M; Seibold JR
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v46-7. PubMed ID: 18784143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of systemic-sclerosis-related digital ulcers with a selective endothelin type A receptor antagonist (sitaxentan).
    Gholam P; Sehr T; Enk A; Hartmann M
    Dermatology; 2009; 219(2):171-3. PubMed ID: 19590168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of sclerodermal finger ulcers.
    Gahhos F; Ariyan S; Frazier WH; Cuono CB
    J Hand Surg Am; 1984 May; 9(3):320-7. PubMed ID: 6725888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of lipid microspheres containing prostaglandin E1 ointment to peripheral ischemic ulcers.
    Sakakibara Y; Jikuya T; Mitsui T
    Dermatology; 1997; 195(3):253-7. PubMed ID: 9407173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bosentan for digital ulcers in patients with systemic sclerosis.
    Nagai Y; Hasegawa M; Hattori T; Okada E; Tago O; Ishikawa O
    J Dermatol; 2012 Jan; 39(1):48-51. PubMed ID: 21955007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in disability as measured by the Health Assessment Questionnaire between patients with and without digital ulcers in systemic sclerosis: a post hoc analysis of pooled data from two randomised controlled trials in digital ulcers using bosentan.
    Zelenietz C; Pope J
    Ann Rheum Dis; 2010 Nov; 69(11):2055-6. PubMed ID: 20959328
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).
    Tiev KP; Diot E; Clerson P; Dupuis-Siméon F; Hachulla E; Hatron PY; Constans J; Cirstéa D; Farge-Bancel D; Carpentier PH
    J Rheumatol; 2009 Jul; 36(7):1470-6. PubMed ID: 19487271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Digital ulcers in systemic scleroderma].
    Lok C; Mouthon L; Ségard M; Richard MA; Guillevin L
    Ann Dermatol Venereol; 2011 Nov; 138(11):762-8; quiz 761, 769. PubMed ID: 22078040
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of bosentan in digital ischemic ulcers.
    Todoli Parra JA; Hernández MM; Arrébola López MA
    Ann Vasc Surg; 2010 Jul; 24(5):690.e1-4. PubMed ID: 20579585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of topical nitroglycerin on transcutaneous oxygen.
    Romanelli M; Katz MH; Alvarez AF; Eaglstein WH; Falanga V
    Br J Dermatol; 1991 Apr; 124(4):354-7. PubMed ID: 1902742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleroderma and impotence: response to nitroglycerin applied to the fingers and penis.
    Ahmad S
    South Med J; 1990 Dec; 83(12):1495. PubMed ID: 2123566
    [No Abstract]   [Full Text] [Related]  

  • 14. Allergic contact dermatitis from glyceryl trinitrate ointment.
    McKenna KE
    Contact Dermatitis; 2000 Apr; 42(4):246. PubMed ID: 10750866
    [No Abstract]   [Full Text] [Related]  

  • 15. Bosentan is effective against digital ulcerations and hyperkeratosis in systemic sclerosis.
    Kurgyis Z; Varga R; Sick I; Lang MU; Ruzicka T; Sárdy M
    Acta Derm Venereol; 2011 Oct; 91(6):716-7. PubMed ID: 21879251
    [No Abstract]   [Full Text] [Related]  

  • 16. Digital ulcers: overt vascular disease in systemic sclerosis.
    Steen V; Denton CP; Pope JE; Matucci-Cerinic M
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii19-24. PubMed ID: 19487218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Predict Study: low risk for digital ulcer development in patients with systemic sclerosis with increasing disease duration and lack of topoisomerase-1 antibodies.
    Hunzelmann N; Riemekasten G; Becker MO; Moinzadeh P; Kreuter A; Melchers I; Mueller-Ladner U; Meier F; Worm M; Lee H; Herrgott I; Pfeiffer C; Fierlbeck G; Henes J; Juche A; Zeidler G; Mensing H; Günther C; Sárdy M; Burkhardt H; Koehm M; Kuhr K; Krieg T; Sunderkötter C
    Br J Dermatol; 2016 Jun; 174(6):1384-7. PubMed ID: 26708835
    [No Abstract]   [Full Text] [Related]  

  • 18. [Digital ulcers in systemic sclerosis].
    Guillevin L
    Presse Med; 2008 Apr; 37(4 Pt 2):735-6. PubMed ID: 18258409
    [No Abstract]   [Full Text] [Related]  

  • 19. Hand and foot ulcers in Nigerian diabetics - a comparative study.
    Akintewe TA; Akanji AO; Odunsan O
    Trop Geogr Med; 1983 Dec; 35(4):353-5. PubMed ID: 6670119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hand involvement in systemic sclerosis].
    Mouthon L
    Presse Med; 2013 Dec; 42(12):1616-26. PubMed ID: 24268960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.